高频生理数据中的时间戳标注:评估CENTER-TBI数据集中标注合理性的方法
本研究回顾性分析CENTER-TBI高频神经监测数据集中205例患者的15,455条时间戳干预标注,开发并演示三步方法学框架:第一步目视检查物理治疗和吸痰标注的整体合理性,90.2%文件为中度或高度证据;第二步基于颅内压标准(标注前需ICP>20 mmHg持续≥5 min)对渗透治疗标注进行自动分类,388条中140条(36.1%)被拒;第三步将有效标注分为有效(ICP下降≥10 mmHg或正常化)和无效,分别占67.7%和32.3%。被拒事件在低证据文件中更常见(57.3% vs 18.0%,p<0.001)。该框架支持目视检查与自动分类的一致性,但需外部验证。
要点
- 在205例CENTER-TBI患者中识别15,455条时间戳干预标注,目视检查90.2%文件有中度或高度标注-信号关系证据。
- 对76例患者的388条渗透治疗标注,36.1%(140条)因标注前无持续颅内高压(ICP>20 mmHg持续≥5 min)被自动拒绝。
- 248条有效渗透治疗标注中,67.7%有效(ICP下降≥10 mmHg或正常化),32.3%无效。
- 被拒事件在低证据文件中更常见(57.3% vs 18.0%,p<0.001),支持目视与自动分类的一致性。
- 该框架可推广至其他标注干预,但需外部验证证明算法泛化性。
适用人群与场景
- CENTER-TBI高频神经监测数据集中的205例创伤性脑损伤患者,包含物理治疗、吸痰和渗透治疗的时间戳临床标注。
- 原文未提及排除人群或具体急诊/ICU场景限制。
诊断标准与关键阈值
- Step 2拒绝标准:渗透治疗标注前无持续颅内高压,即ICP>20 mm Hg持续≥5 min。
- Step 3有效性标准:标注后ICP下降≥10 mm Hg或正常化定义为有效,否则无效。
- Step 1目视检查将文件分为中度或高度证据、低证据(9.8%)。
处置流程与药物剂量
- 第一步:对物理治疗和吸痰标注进行目视检查,评估患者层面标注-信号关系的整体合理性。
- 第二步:对渗透治疗标注前时段应用基于ICP的分类,拒绝无持续颅内高压(ICP>20 mm Hg持续≥5 min)的标注。
- 第三步:对保留的标注,根据标注后ICP趋势分为有效(ICP下降≥10 mm Hg或正常化)或无效。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 回顾性分析CENTER-TBI高频数据集,205例患者,15,455条时间戳干预标注。
- Step 1目视检查:90.2%文件有中度或高度标注-信号关系证据,9.8%为低证据。
- Step 2自动分类:388条渗透治疗标注(76例患者),140条(36.1%)被拒,248条(63.9%)保留。
- Step 3有效性分类:有效67.7%,无效32.3%。
- 被拒事件在低证据文件中更常见(57.3% vs 18.0%,p<0.001)。
证据类型、等级与局限
- 回顾性方法学研究,基于CENTER-TBI高频数据集,非随机对照试验。
- 局限:需外部验证证明算法泛化性;原文未提及其他局限。
对床旁实践的改变
- 提示在利用高频神经监测数据评估治疗反应前,应系统评估时间戳标注的生理合理性,避免依赖缺乏持续颅内高压前提的渗透治疗标注。
- 该框架可帮助识别低证据文件(标注-信号关系弱),此类文件中被拒标注比例更高。
- 原文未提及对具体临床处置流程的直接改变。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND/OBJECTIVE: High-resolution neuromonitoring data with time-stamped clinical annotations offer valuable insights into treatment responses, though reliability is limited by manual documentation. This study aims to develop and demonstrate a three-step methodological framework to evaluate the plausibility of time-stamped clinical annotations using a high-frequency dataset. The framework integrates visual inspection of reference annotations and automated classification based on predefined physiological criteria.
METHODS: Annotated interventions in the High-Resolution Collaborative European Neuro Trauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) dataset were retrospectively analysed. Step 1 included visually inspecting physiotherapy and suctioning annotations to assess the overall plausibility of annotations at the patient level. In Step 2, an intracranial pressure (ICP)-based classification was applied to the period before osmotherapy annotations. Rejected annotations were those without sustained intracranial hypertension (ICP > 20 mm Hg for ≥ 5 min) beforehand. Step 3 classified the accepted annotations as effective (ICP reduction ≥ 10 mm Hg or normalisation) or ineffective on the basis of the post-annotation ICP trend.
RESULTS: Across 205 patients, 15,455 annotated interventions were identified. Visual inspection (Step 1) classified 90.2% of files as having moderate or high evidence of an annotation-signal relationship and 9.8% as having low evidence. The automated analysis (Step 2) identified 388 osmotherapy annotations in 76 patients; 140 (36.1%) were rejected, and 248 (63.9%) were retained. Step 3 found that, among valid events, 67.7% were effective and 32.3% ineffective. Rejected events were more frequent in low-evidence files (57.3%%) than in high-evidence ones (18.0%, p < 0.001).
CONCLUSIONS: This study provides the first systematic evaluation of time-stamped annotations in the CENTER-TBI high-resolution dataset. Concordant findings obtained using visual inspection and automated classification supports the credibility of both approaches and illustrates a framework for evaluating physiological plausibility, demonstrated here for osmotherapy but applicable to other annotated interventions. External validation is needed to prove the generalisability of the proposed algorithm.
参考来源
- Turella S, Beqiri E, Bögli SY, et al. Time-Stamped Annotations in High-Frequency Physiological Data: Evaluating an Approach for Assessing Annotation Plausibility in the CENTER-TBI Dataset. Neurocrit Care. 2026. PMID: 42686990. doi:10.1007/s12028-026-02637-6
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。